Design, parallel synthesis of Biginelli 1,4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies.
In: Bioorganic chemistry, Jg. 117 (2021-12-01), S. 105462
academicJournal
Zugriff:
Biginelli 1,4-dihydropyrimidines are extensively screened for their potential anticancer activity in the last decade. In this context, a series of Biginelli 1,4-dihydropyrimidines were designed and synthesised using PTSA as an efficient catalyst. The synthesised 1,4-dihydropyrimidines were screened for their anticancer activity against MCF-7 breast cancer cells by measuring cytotoxicity. The compounds exhibited activity ranging from weak to significant in terms of percentage cytotoxicity which is proportional to the anticancer activity. Amongst the screened compounds, compounds 4, 6 and 8 exhibited potential anticancer activity. Furthermore, CoMSIA studies were performed to derive the structure activity relationships in a 3D grid space by plotting experimental vs predicted cytotoxic activities. We have an opinion that, this developed model helps us in future to develop more potential 1,4-dihydropyrimidines for their cytotoxicity or anticancer activity.
(Copyright © 2021 Elsevier Inc. All rights reserved.)
Titel: |
Design, parallel synthesis of Biginelli 1,4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies.
|
---|---|
Autor/in / Beteiligte Person: | Faizan, S ; Prashantha Kumar, BR ; Lalitha Naishima, N ; Ashok, T ; Justin, A ; Vijay Kumar, M ; Bistuvalli Chandrashekarappa, R ; Manjunathaiah Raghavendra, N ; Kabadi, P ; Adhikary, L |
Zeitschrift: | Bioorganic chemistry, Jg. 117 (2021-12-01), S. 105462 |
Veröffentlichung: | Amsterdam : Elsevier ; <i>Original Publication</i>: New York, London, Academic Press., 2021 |
Medientyp: | academicJournal |
ISSN: | 1090-2120 (electronic) |
DOI: | 10.1016/j.bioorg.2021.105462 |
Schlagwort: |
|
Sonstiges: |
|